Co-Authors
This is a "connection" page, showing publications co-authored by BRETT CARTER and JEREMY J ERASMUS.
Connection Strength
2.747
-
Predicting Malignant Nodules from Screening CTs. J Thorac Oncol. 2016 12; 11(12):2045-2047.
Score: 0.571
-
Acute Thoracic Findings in Oncologic Patients. J Thorac Imaging. 2015 Jul; 30(4):233-46.
Score: 0.518
-
Small cell lung carcinoma: staging, imaging, and treatment considerations. Radiographics. 2014 Oct; 34(6):1707-21.
Score: 0.492
-
Revisions to the TNM Staging of Lung Cancer: Rationale, Significance, and Clinical Application. Radiographics. 2018 Mar-Apr; 38(2):374-391.
Score: 0.156
-
Incidental Findings in Lung Cancer Screening: Which Ones are Relevant? Semin Roentgenol. 2017 Jul; 52(3):156-160.
Score: 0.148
-
Quality and Value of Subspecialty Reinterpretation of Thoracic CT Scans of Patients Referred to a Tertiary Cancer?Center. J Am Coll Radiol. 2017 Aug; 14(8):1109-1118.
Score: 0.147
-
Current Controversies in Lung Cancer Staging. J Thorac Imaging. 2016 Jul; 31(4):201-14.
Score: 0.139
-
Staging of lung cancer. Clin Chest Med. 2015 Jun; 36(2):179-96, vii-viii.
Score: 0.127
-
Pitfalls and limitations in non-small cell lung cancer staging. Semin Roentgenol. 2015 Jul; 50(3):175-82.
Score: 0.126
-
Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role? J Thorac Oncol. 2014 Aug; 9(8):1202-6.
Score: 0.122
-
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial. Radiother Oncol. 2021 09; 162:60-67.
Score: 0.049
-
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy. J Immunother Cancer. 2019 09 04; 7(1):237.
Score: 0.043
-
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma. Cancer Discov. 2018 07; 8(7):822-835.
Score: 0.040
-
Early clinical esophageal adenocarcinoma (cT1): Utility of CT in regional nodal metastasis detection and can the clinical accuracy be improved? Eur J Radiol. 2017 Mar; 88:56-60.
Score: 0.036
-
Characterizing proton-activated materials to develop PET-mediated proton range verification markers. Phys Med Biol. 2016 06 07; 61(11):N291-310.
Score: 0.034